Small Molecules, Drug-Device Comvo Product
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
24
NCT04601766
A Phase I, Two-phase, Crossover Study to Evaluate the Safety, Tolerability and Pharmacokinetics of APL-1501 ER Tablets
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 30, 2020
Completion: Feb 1, 2021
NCT06435039
A Study of APL-1501 Extended Release Capsules Compared to APL-1202 Immediate Release Tablets in Healthy Volunteers
Role: Collaborator
Start: Jun 21, 2024
Completion: Jul 16, 2024
Loading map...